SevoFlo
-
EU/2/02/035/007
Zoetis Belgium S.A., Beļģija
QN01AB08
dogs; cats
Vairāk
Medicinal product information
Pharmaceutical form:
inhalation vapour, liquid
International name (active substance):
Sevoflurane
Distribution category:
To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release
Aesica Queenborough, Lielbritānija;Abbott Logistics , Nīderlande
Date of authorisation/renewal:
06-Nov-2007
Marketing authorisation valid until:
Unlimited time period
Marketing authorisation procedure:
EU
Package leaflet:
*
-
Labelling text:
*
-
Summary of product characteristics:
*
-
*
More detailed information available on the European Medicines Agency website
Products
ID
Strength
Package size
Primary packaging
Labelling
EU/2/02/035/007
100 %
1
Flakons, 250 ml
-
Zuprevo
180 mg/ml
EU/2/11/124/005
Intervet International B.V., Nīderlande
QJ01FA96
cattle
Vairāk
Medicinal product information
Pharmaceutical form:
solution for injection
International name (active substance):
Tildipirosin
Distribution category:
To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release
Intervet International GmbH, Vācija
Date of authorisation/renewal:
22-May-2016
Marketing authorisation valid until:
Unlimited time period
Marketing authorisation procedure:
EU
Package leaflet:
*
-
Labelling text:
*
-
Summary of product characteristics:
*
-
*
More detailed information available on the European Medicines Agency website
Products
ID
Strength
Package size
Primary packaging
Labelling
EU/2/11/124/005
180 mg/ml
1
Flakons, 20 ml
-
Procox
-
EU/2/11/123/002
Vetoquinol S.A., Francija
QP52AX
dogs
Vairāk
Medicinal product information
Pharmaceutical form:
suspension for oral use
International name (active substance):
Toltrazuril,Emodepside
Distribution category:
To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release
KVP Pharma + Veterinar Produkte GmbH, Vācija
Date of authorisation/renewal:
14-Jan-2016
Marketing authorisation valid until:
Unlimited time period
Marketing authorisation procedure:
EU
Package leaflet:
*
-
Labelling text:
*
-
Summary of product characteristics:
*
-
*
More detailed information available on the European Medicines Agency website
Products
ID
Strength
Package size
Primary packaging
Labelling
EU/2/11/123/002
1
Stikla pudelīte, 20 ml
-
Inflacam
1.5 mg/ml
EU/2/11/134/003
Chanelle Pharmaceuticals Manufacturing Ltd., Īrija
QM01AC06
dogs
Vairāk
Medicinal product information
Pharmaceutical form:
suspension for oral use
International name (active substance):
Meloxicam
Distribution category:
To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release
Chanelle Pharmaceuticals Manufacturing Ltd., Īrija
Date of authorisation/renewal:
09-Nov-2016
Marketing authorisation valid until:
Unlimited time period
Marketing authorisation procedure:
EU
Package leaflet:
*
-
Labelling text:
*
-
Summary of product characteristics:
*
-
*
More detailed information available on the European Medicines Agency website
Products
ID
Strength
Package size
Primary packaging
Labelling
EU/2/11/134/003
1,5 mg/ml
1
Pudelīte, 100 ml
-
Tulissin
100 mg/ml
EU/2/20/252/006
VIRBAC, Francija
QJ01FA94
cattle
Vairāk
Medicinal product information
Pharmaceutical form:
solution for injection
International name (active substance):
Tulathromycin
Distribution category:
To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release
FAREVA AMBOISE, Francija;VIRBAC, Francija
Date of authorisation/renewal:
24-Apr-2020
Marketing authorisation valid until:
Unlimited time period
Marketing authorisation procedure:
EU
Package leaflet:
*
-
Labelling text:
*
-
Summary of product characteristics:
*
-
*
More detailed information available on the European Medicines Agency website
Products
ID
Strength
Package size
Primary packaging
Labelling
EU/2/20/252/006
100 mg/ml
1
Stikla flakons, 500 ml
-
Purevax RCP
-
EU/2/04/052/004
Boehringer Ingelheim Vetmedica GmbH, Vācija
QI06AH09
cats
Vairāk
Medicinal product information
Pharmaceutical form:
lyophilisate and solvent for suspension for injection
International name (active substance):
Attenuated feline rhinotracheitis herpesvirus,Live attenuated feline panleucopenia virus,Inactivated feline Calicivirosis antigens
Distribution category:
To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release
Merial Laboratory of Lyon Porte des Alpes, Francija
Date of authorisation/renewal:
25-Jan-2010
Marketing authorisation valid until:
Unlimited time period
Marketing authorisation procedure:
EU
Package leaflet:
*
-
Labelling text:
*
-
Summary of product characteristics:
*
-
*
More detailed information available on the European Medicines Agency website
Products
ID
Strength
Package size
Primary packaging
Labelling
EU/2/04/052/004
1 devas/flakonā
50
Pudele, 1 deva
-
Bovilis Cryptium
-
EU/2/23/303/004
Intervet International B.V., Nīderlande
QI02AO02
Cattle (pregnant heifer); Cattle (pregnant cow)
Vairāk
Medicinal product information
Pharmaceutical form:
emulsion for injection
International name (active substance):
Cryptosporidium parvum, glycoprotein gp40
Distribution category:
To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release
-
Date of authorisation/renewal:
23-Nov-2023
Marketing authorisation valid until:
Unlimited time period
Marketing authorisation procedure:
EU
Package leaflet:
*
-
Labelling text:
*
-
Summary of product characteristics:
*
-
*
More detailed information available on the European Medicines Agency website
Products
ID
Strength
Package size
Primary packaging
Labelling
EU/2/23/303/004
1
Stikla flakons, 100 ml
-
Trilorale
50 mg/ml
EU/2/24/313/007
Axience, Francija
QH02CA01
dogs
Vairāk
Medicinal product information
Pharmaceutical form:
Oral solution
International name (active substance):
Trilostane
Distribution category:
To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release
-
Date of authorisation/renewal:
06-May-2024
Marketing authorisation valid until:
Unlimited time period
Marketing authorisation procedure:
EU
Package leaflet:
*
-
Labelling text:
*
-
Summary of product characteristics:
*
-
*
More detailed information available on the European Medicines Agency website
Products
ID
Strength
Package size
Primary packaging
Labelling
EU/2/24/313/007
50 mg/ml
1
Polipropilēna pudele, 72 ml
-
Vaxxitek HVT+IBD+H5
-
EU/2/25/354/001
Boehringer Ingelheim Vetmedica GmbH, Vācija
QI01AD
chickens; turkeys; embryonated chicken eggs
Vairāk
Medicinal product information
Pharmaceutical form:
concentrate and solvent for suspension for injection
International name (active substance):
Turkey herpesvirus, strain rHVT-IBD-H5, expressing the VP2 protein gene of Infectious bursal disease virus and haemagglutinin gene of Avian influenza virus subtype H5, Live
Distribution category:
To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release
-
Date of authorisation/renewal:
19-Nov-2025
Marketing authorisation valid until:
18-Nov-2026
Marketing authorisation procedure:
EU
Package leaflet:
*
-
Labelling text:
*
-
Summary of product characteristics:
*
-
*
More detailed information available on the European Medicines Agency website
Products
ID
Strength
Package size
Primary packaging
Labelling
EU/2/25/354/001
1
Stikla ampula, 2000 deva
-
Emdocam
20 mg/ml
EU/2/11/128/001
Emdoka bvba, Beļģija
QM01AC06
cattle; pigs; horses
Vairāk
Medicinal product information
Pharmaceutical form:
solution for injection
International name (active substance):
Meloxicam
Distribution category:
To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release
Produlab Pharma b.v., Nīderlande
Date of authorisation/renewal:
21-Jun-2016
Marketing authorisation valid until:
Unlimited time period
Marketing authorisation procedure:
EU
Package leaflet:
*
-
Labelling text:
*
-
Summary of product characteristics:
*
-
*
More detailed information available on the European Medicines Agency website
Products
ID
Strength
Package size
Primary packaging
Labelling
EU/2/11/128/001
20 mg/ml
1
Pudelīte (caurspīdīga), 50 ml
-
Parvoruvax
-
V/I/24/0071
Ceva Sante Animale', Francija
QI09AL01
pigs
Vairāk
Medicinal product information
Pharmaceutical form:
suspension for injection
International name (active substance):
Inactivated porcine parvovirus, Erysipelothrix rhusiopathiae
Distribution category:
To be used only by veterinary surgeon
Manufacturer(s) responsible for batch release
Ceva-Phylaxia Veterinary Biologicals Co. Ltd., Ungārija
Date of authorisation/renewal:
26-Nov-2024
Marketing authorisation valid until:
25-Nov-2029
Marketing authorisation procedure:
I
Package leaflet:
[DOCX] 26082025LI (26-Aug-2025)
Labelling text:
See products section
Summary of product characteristics:
-
Products
ID
Strength
Package size
Primary packaging
Labelling
V/I/24/0071-01
1
Flakons, 25 deva
[PDF]
[PDF]
Zuprevo
180 mg/ml
EU/2/11/124/008
Intervet International B.V., Nīderlande
QJ01FA96
cattle
Vairāk
Medicinal product information
Pharmaceutical form:
solution for injection
International name (active substance):
Tildipirosin
Distribution category:
To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release
Intervet International GmbH, Vācija
Date of authorisation/renewal:
22-May-2016
Marketing authorisation valid until:
Unlimited time period
Marketing authorisation procedure:
EU
Package leaflet:
*
-
Labelling text:
*
-
Summary of product characteristics:
*
-
*
More detailed information available on the European Medicines Agency website
Products
ID
Strength
Package size
Primary packaging
Labelling
EU/2/11/124/008
180 mg/ml
1
Flakons, 250 ml
-
Trocoxil
20 mg
EU/2/08/084/002
Zoetis Belgium S.A., Beļģija
QM01AH92
dogs
Vairāk
Medicinal product information
Pharmaceutical form:
chewable tablets
International name (active substance):
Mavacoxib
Distribution category:
To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release
Pfizer (Heinrich Mack Nachf), Vācija
Date of authorisation/renewal:
22-Sep-2008
Marketing authorisation valid until:
Unlimited time period
Marketing authorisation procedure:
EU
Package leaflet:
*
-
Labelling text:
*
-
Summary of product characteristics:
*
-
*
More detailed information available on the European Medicines Agency website
Products
ID
Strength
Package size
Primary packaging
Labelling
EU/2/08/084/002
20 mg/tabl.
2
Alumīnija blisteris, 1 tablete
-
Loxitab
1 mg
EU/2/23/301/003
CP-Pharma Handelsgesellschaft GmbH, Vācija
QM01AC06
dogs
Vairāk
Medicinal product information
Pharmaceutical form:
tablets
International name (active substance):
Meloxicam
Distribution category:
To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release
-
Date of authorisation/renewal:
19-Oct-2023
Marketing authorisation valid until:
Unlimited time period
Marketing authorisation procedure:
EU
Package leaflet:
*
-
Labelling text:
*
-
Summary of product characteristics:
*
-
*
More detailed information available on the European Medicines Agency website
Products
ID
Strength
Package size
Primary packaging
Labelling
EU/2/23/301/003
5
PVH/PE/PVDH-Al blisteris, 10 tablete
-
Loxicom
0.5 mg/ml
EU/2/08/090/009
Norbrook Laboratories (Ireland) Limited, Īrija
QM01AC06
cats
Vairāk
Medicinal product information
Pharmaceutical form:
solution for injection
International name (active substance):
Meloxicam
Distribution category:
To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release
Norbrook Laboratories Limited, Lielbritānija
Date of authorisation/renewal:
12-Mar-2014
Marketing authorisation valid until:
Unlimited time period
Marketing authorisation procedure:
EU
Package leaflet:
*
-
Labelling text:
*
-
Summary of product characteristics:
*
-
*
More detailed information available on the European Medicines Agency website
Products
ID
Strength
Package size
Primary packaging
Labelling
EU/2/08/090/009
0,5 mg/ml
1
Polietilēna pudele, 15 ml
-
Prevestrus vet
25 mg/tabl.
EU/2/25/338/001
Vetcare Oy, Somija
-
dogs (bitches)
Vairāk
Medicinal product information
Pharmaceutical form:
film-coated tablets
International name (active substance):
Finrozole
Distribution category:
To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release
-
Date of authorisation/renewal:
23-Apr-2025
Marketing authorisation valid until:
Unlimited time period
Marketing authorisation procedure:
EU
Package leaflet:
*
-
Labelling text:
*
-
Summary of product characteristics:
*
-
*
More detailed information available on the European Medicines Agency website
Products
ID
Strength
Package size
Primary packaging
Labelling
EU/2/25/338/001
1
Blisteris, 7 tablete
-
Emepax 24 mg
24 mg
EU/2/26/363/003
Axience, Francija
QA04AD90
dogs
Vairāk
Medicinal product information
Pharmaceutical form:
chewable tablets
International name (active substance):
Maropitant citrate monohydrate
Distribution category:
To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release
Lelypharma B.V., Nīderlande
Date of authorisation/renewal:
26-Mar-2026
Marketing authorisation valid until:
Unlimited time period
Marketing authorisation procedure:
EU
Package leaflet:
*
-
Labelling text:
*
-
Summary of product characteristics:
*
-
*
More detailed information available on the European Medicines Agency website
Products
ID
Strength
Package size
Primary packaging
Labelling
EU/2/26/363/003
3
OPA/Al/PVH-Al blisteris, 4 tablete
-
Nobilis IB 4 - 91
-
EU/2/98/006/018
Intervet International Booxmer, Nīderlande
QI01AD07
chickens
Vairāk
Medicinal product information
Pharmaceutical form:
lyophilisate for suspension
International name (active substance):
Live attenuated Infectious Bronchitis virus
Distribution category:
To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release
-
Date of authorisation/renewal:
21-May-2008
Marketing authorisation valid until:
Unlimited time period
Marketing authorisation procedure:
EU
Package leaflet:
*
-
Labelling text:
*
-
Summary of product characteristics:
*
-
*
More detailed information available on the European Medicines Agency website
Products
ID
Strength
Package size
Primary packaging
Labelling
EU/2/98/006/018
12
Polipropilēna trauciņš, 10000 deva
-
Bovela
-
EU/2/14/176/016
Boehringer Ingelheim Vetmedica GmbH, Vācija
QI02AD02
cattle
Vairāk
Medicinal product information
Pharmaceutical form:
lyophilisate and solvent for suspension for injection
International name (active substance):
Modified live BVDV-1, non-cytopathic parent strain KE-9,Modified live bovine viral diarrhoea virus type 2, non-cytopathic parent strain NY-93
Distribution category:
To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release
Boehringer Ingelheim Animal Health USA Inc., ASV
Date of authorisation/renewal:
21-Dec-2019
Marketing authorisation valid until:
Unlimited time period
Marketing authorisation procedure:
EU
Package leaflet:
*
-
Labelling text:
*
-
Summary of product characteristics:
*
-
*
More detailed information available on the European Medicines Agency website
Products
ID
Strength
Package size
Primary packaging
Labelling
EU/2/14/176/016
10
Stikla flakons, 50 deva
-
Chanhold
360 mg
EU/2/19/236/016
Chanelle Pharmaceuticals Manufacturing Ltd., Īrija
QP54AA05
dogs 40,1–60,0 kg
Vairāk
Medicinal product information
Pharmaceutical form:
spot-on solution
International name (active substance):
Selamectin
Distribution category:
To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release
Chanelle Pharmaceuticals Manufacturing Ltd., Īrija
Date of authorisation/renewal:
17-Apr-2019
Marketing authorisation valid until:
Unlimited time period
Marketing authorisation procedure:
EU
Package leaflet:
*
-
Labelling text:
*
-
Summary of product characteristics:
*
-
*
More detailed information available on the European Medicines Agency website
Products
ID
Strength
Package size
Primary packaging
Labelling
EU/2/19/236/016
120 mg/ml
6
Plastmasas pipete, 3 ml
-